Phase I/II study on stereotactic hypofractionated onceweekly radiation therapy (SHORT) for localized prostate cancer.

被引：0
|
作者：
Mallick, Indranil
Arunsingh, Moses
Prasath, Sriram
Arun, B.
Roy, Paromita
Dabkara, Deepak
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 06期
关键词：
D O I：
10.1200/JCO.2017.35.6_suppl.130
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
130
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Hypofractionated intensity modulated irradiation for localized prostate cancer, results from a phase I/II feasibility study
    Junius, Sara
    Haustermans, Karin
    Bussels, Barbara
    Oyen, Raymond
    Vanstraelen, Bianca
    Depuydt, Tom
    Verstraete, Jan
    Joniau, Steven
    Van Poppel, Hendrik
    RADIATION ONCOLOGY, 2007, 2 (1)
  • [22] Phase II study of enzalutamide monotherapy with radiation therapy for intermediate risk prostate cancer.
    Bubley, Glenn
    Kaplan, Irving D.
    Werner, Lillian
    Bhatt, Rupal Satish
    Taplin, Mary Ellen
    Mahoney, Kathleen Margaret
    Nguyen, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [23] Stereotactic body radiation therapy for clinically localized prostate cancer
    Vorobyov, N. A.
    Martynova, N. I.
    Mikhailov, A. V.
    Gutsalo, Yu. V.
    Kubasov, A. V.
    ONKOUROLOGIYA, 2018, 14 (02): : 122 - 129
  • [24] Stereotactic radiation therapy of localized prostate cancer using cyberknife
    Choi, C.
    Cho, C.
    Kim, G.
    Park, K.
    Jo, M.
    Lee, C.
    Yoo, S.
    Kim, M.
    Yang, K.
    Yoo, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S375 - S375
  • [25] Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer
    Chen, V.
    Suy, S.
    Oermann, E. K.
    Uhm, S.
    Kim, J. S.
    Hanscom, H. N.
    Collins, B. T.
    Dritschilo, A.
    Lynch, J.
    Collins, S. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S376 - S376
  • [26] Focal Therapy for Localized Prostate Cancer: A Phase I/II Trial
    Ahmed, H. U.
    Freeman, A.
    Kirkham, A.
    Sahu, M.
    Scott, R.
    Allen, C.
    Van der Meulen, J.
    Emberton, M.
    JOURNAL OF UROLOGY, 2011, 185 (04): : 1246 - 1254
  • [27] Four-year outcomes of hypofractionated proton therapy for localized prostate cancer.
    Grewal, Amardeep S.
    Schonewolf, Caitlin
    Both, Stefan
    Lam, Sarah
    Mazzoni, Susan
    Bekelman, Justin E.
    Christodouleas, John Paul
    Vapiwala, Neha
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [28] Pilot study of moderately-hypofractionated intensity-modulated radiation therapy over 3 weeks for localized prostate cancer.
    Nakamura, Kiyonao
    Inokuchi, Haruo
    Ikeda, Itaru
    Kamba, Tomomi
    Inoue, Takahiro
    Yamasaki, Toshinari
    Kobayashi, Takashi
    Ogawa, Osamu
    Mizowaki, Takashi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [29] Predictors of prostate cancer-specific anxiety following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer.
    Salari, Kamran
    Aghdam, Nima
    Gersony, Luara
    Danner, Malika
    Ayoob, Marilyn
    Yung, Thomas M.
    Kataria, Shaan
    Lei, Siyuan
    Collins, Brian Timothy
    Kumar, Deepak
    Lischalk, Jonathan W.
    Dritschilo, Anatoly
    Suy, Simeng
    Lynch, John J.
    Collins, Sean P.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [30] Stereotactic ablative radiation therapy for the treatment of oligometastatic prostate cancer.
    Tran, Phuoc T.
    Moyer, C. Leigh
    Phillips, Ryan
    Radwan, Noura
    Ross, Ashley
    Reyes, Diane K.
    Wright, Jean
    Antonarakis, Emmanuel S.
    Song, Daniel Y.
    Deville, Curtiland
    Walsh, Patrick C.
    DeWeese, Theodore L.
    Carducci, Michael Anthony
    Schaeffer, Edward M.
    Pienta, Kenneth J.
    Eisenberger, Mario A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345